Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia T Geyer

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|July 27, 2018
Myeloid Neoplasms with Germline PredispositionJulia T Geyer
Cytometry. Part B, Clinical Cytometry|June 28, 2024
Updates on germline predisposition in pediatric hematologic malignancies: What is the role of flow cytometry?Nadine Demko, Julia T Geyer
Current Opinion in Rheumatology|December 3, 2010
IgG4-associated sialadenitisJulia T Geyer, Vikram Deshpande
Surgical Pathology Clinics|May 6, 2023
Current Landscape of Ancillary Diagnostic Testing in Chronic Lymphocytic LeukemiaJulia T Geyer, Michael J Kluk
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 13, 2023
Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated ClassificationsYen-Chun Liu, Julia T Geyer
Seminars in Diagnostic Pathology|August 26, 2020
B-cell neoplasms and Hodgkin lymphoma in the spleenJulia T Geyer, Sonam Prakash, Attilio Orazi
Seminars in Diagnostic Pathology|November 17, 2020
T-cell neoplasms in the spleenOsvaldo Padilla, Wayne Tam, Julia T Geyer
American Journal of Clinical Pathology|December 24, 2025
Review of flow cytometry findings and associated scoring approaches for identifying myelodysplastic syndrome and the future role of machine learning in improving the diagnostic algorithmNadine Demko, Julia T Geyer, Paul D Simonson
Annals of Medicine|April 11, 2014
Myelodysplastic syndromes in the United States: an update for cliniciansJesse D Troy, Ehab Atallah, Julia T Geyer, et al.
Annals of Hematology|February 27, 2025
t(14;22)(q32;q11) translocation involving IGH and IGL acquired at progression of splenic marginal zone lymphoma treated with rituximab, ibrutinib, and obinutuzumabJulia T Geyer, Jia Ruan, Michael J Kluk, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|July 27, 2018
Myeloid Neoplasms with Germline PredispositionJulia T Geyer
Cytometry. Part B, Clinical Cytometry|June 28, 2024
Updates on germline predisposition in pediatric hematologic malignancies: What is the role of flow cytometry?Nadine Demko, Julia T Geyer
Current Opinion in Rheumatology|December 3, 2010
IgG4-associated sialadenitisJulia T Geyer, Vikram Deshpande
Surgical Pathology Clinics|May 6, 2023
Current Landscape of Ancillary Diagnostic Testing in Chronic Lymphocytic LeukemiaJulia T Geyer, Michael J Kluk
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 13, 2023
Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated ClassificationsYen-Chun Liu, Julia T Geyer
Seminars in Diagnostic Pathology|August 26, 2020
B-cell neoplasms and Hodgkin lymphoma in the spleenJulia T Geyer, Sonam Prakash, Attilio Orazi
Seminars in Diagnostic Pathology|November 17, 2020
T-cell neoplasms in the spleenOsvaldo Padilla, Wayne Tam, Julia T Geyer
American Journal of Clinical Pathology|December 24, 2025
Review of flow cytometry findings and associated scoring approaches for identifying myelodysplastic syndrome and the future role of machine learning in improving the diagnostic algorithmNadine Demko, Julia T Geyer, Paul D Simonson
Annals of Medicine|April 11, 2014
Myelodysplastic syndromes in the United States: an update for cliniciansJesse D Troy, Ehab Atallah, Julia T Geyer, et al.
Annals of Hematology|February 27, 2025
t(14;22)(q32;q11) translocation involving IGH and IGL acquired at progression of splenic marginal zone lymphoma treated with rituximab, ibrutinib, and obinutuzumabJulia T Geyer, Jia Ruan, Michael J Kluk, et al.
Pageof 6